HealthMore in Health→
Revolution Medicines Signals a New Phase for an Experimental Pancreatic Cancer Drug
Revolution Medicines has started shipping an experimental pancreatic cancer drug, and its CEO says an FDA submission is coming soon.
Key Takeaways
- Revolution Medicines says it has started shipping an experimental pancreatic cancer drug.
- CEO Mark Goldsmith said an FDA submission is expected soon.
DE
DT Editorial Team··via statnews.com